<DOC>
	<DOCNO>NCT00844376</DOCNO>
	<brief_summary>The purpose study estimate relative bioavailability commercial tablet one prototype extemporaneous preparation suspension formulation , assist internal decision make formulation development .</brief_summary>
	<brief_title>Bioavailability Study New Atorvastatin Formulation</brief_title>
	<detailed_description>Estimation Relative Bioavailability</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Healthy male and/or female subject Body Mass Index ( BMI ) approximately 18 30 kg/m2 Any condition possibly affect drug absorption A positive urine drug screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Cardiovascular Diseases</keyword>
</DOC>